WSGR logoWSGR logo
Bryan D. King
Partner
Corporate
Seattle

D206-883-2535

Download vCard
LinkedIn
Open PDF
  • Diverse Background Experience

    In addition to being a corporate partner at the firm, Bryan previously served as corporate counsel to a biopharmaceutical company and was a financial analyst in the investment banking division of Salomon Smith Barney.

  • Representations

    Bryan has advised notable companies and investment banks such as Alpine Immune Sciences, Athira Pharma, Cloudflare, Impinj, NanoString Technologies, Xenon Pharmaceuticals, BofA Securities, Goldman Sachs, J.P. Morgan, and Morgan Stanley.

Bryan King is a partner in the Seattle office of Wilson Sonsini Goodrich & Rosati. His practice focuses on corporate and securities law matters for emerging growth companies, venture capital firms, and public companies.

Bryan was an associate in Wilson Sonsini's Seattle office from 2007 until 2011, when he joined a Seattle-area biopharmaceutical company as corporate counsel. He rejoined the firm in June 2012.

Prior to law school, Bryan was a financial analyst in the investment banking division of Salomon Smith Barney in New York, with a focus on media, telecommunications, and power companies.

Experience

Bryan King is a partner in the Seattle office of Wilson Sonsini Goodrich & Rosati. His practice focuses on corporate and securities law matters for emerging growth companies, venture capital firms, and public companies.

Bryan was an associate in Wilson Sonsini's Seattle office from 2007 until 2011, when he joined a Seattle-area biopharmaceutical company as corporate counsel. He rejoined the firm in June 2012.

Prior to law school, Bryan was a financial analyst in the investment banking division of Salomon Smith Barney in New York, with a focus on media, telecommunications, and power companies.

Focus Areas
Recent Insights
Client Highlights
Wilson Sonsini Advises Lithos Carbon on $57.1 Million Offtake Agreement in Largest-Ever Frontier CDR Purchase
On December 7, 2023, Frontier, an advance market commitment (AMC) that aims to accelerate the development of carbon removal technologies, announced its first enhanced weathering offtake agreements with Lithos Carbon, a San Francisco-based agricultural carbon removal company. Wilson Sonsini Goodrich & Rosati advised Lithos in the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Alpine Immune Sciences on $150 Million Follow-on Public Offering
On November 6, 2023, Alpine Immune Sciences, Inc., a clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the pricing of its underwritten public offering of 8,800,000 shares of its common stock and pre-funded warrants to purchase up to 3,200,000 shares of its common stock, pursuant to its existing shelf registration statement. Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the transaction.
Learn More
View All
WSGR logo
Copyright © 2024 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.